[Federal Register Volume 79, Number 92 (Tuesday, May 13, 2014)]
[Notices]
[Pages 27317-27318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-10965]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Council on Blood Stem Cell Transplantation; Notice of 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Council on Blood Stem Cell Transplantation.
    Date and Time: May 29, 2014, 10:00 a.m. to 4:00 p.m. (Eastern 
Standard Time).
    Place: The meeting will be via audio conference call and Adobe 
Connect Pro.
    Status: The meeting will be open to the public.
    Purpose: Pursuant to Public Law 109-129, 42 U.S.C. 274k (section 
379 of the Public Health Service Act, as amended), the Advisory Council 
on Blood Stem Cell Transplantation (ACBSCT) advises the Secretary of 
the Department of Health and Human Services and the Administrator, 
Health Resources and Services Administration on matters related to the 
activities of the C.W. Bill Young Cell Transplantation Program 
(Program) and the National Cord Blood Inventory Program.
    Agenda: The Council will hear reports from ACBSCT Work Groups 
including: Cord Blood Thawing and Washing; Access to Transplantation; 
and Advancing Hematopoietic Stem Cell Transplantation for 
Hemoglobinopathies. The Council also will hear presentations and 
discussions on topics including: Accreditation; Adverse Event 
Reporting; and Unmet Need. Agenda items are subject to changes as 
priorities indicate.
    After Council discussions, members of the public will have an 
opportunity to provide comments. Because of the Council's full agenda 
and the time frame in which to cover the agenda topics, public comment 
will be limited. All public comments will be included in the record of 
the ACBSCT meeting. Meeting summary notes will be posted on the Program 
Web site at http://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/index.html.
    The draft meeting agenda will be posted on www.blsmeetings.net/ACBSCT. Those participating in this meeting should register by visiting 
www.blsmeetings.net/ACBSCT. The deadline to register for this meeting 
is Wednesday, May 28, 2014. For all logistical questions and concerns, 
please contact Anita Allen, Seamon Corporation, by calling (301) 658-
3442

[[Page 27318]]

or by sending an email to [email protected].
    The public can join the meeting by:
    1. (Audio Portion) Calling the conference number at 888-324-4391 
and providing the Participant Code 2426; AND
    2. (Visual Portion) Connecting to the ACBSCT Adobe Connect Pro 
Meeting using the following URL and entering as GUEST: https://hrsa.connectsolutions.com/acbsct_2/ (copy and paste the link into your 
browser if it does not work directly, and enter as a guest).
    Participants should call and connect 15 minutes prior to the 
meeting in order for logistics to be set up. If you have never attended 
an Adobe Connect meeting, please test your connection using the 
following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by following URL: 
http://www.adobe.com/go/connectpro_overview. Call (301) 443-0437 or 
send an email to [email protected] if you are having trouble connecting 
to the meeting site.
    Public Comment: It is preferred that persons interested in 
providing an oral presentation submit a written request, along with a 
copy of their presentation to: Passy Tongele, MBA, Division of 
Transplantation, Healthcare Systems Bureau, Health Resources and 
Services Administration, Room 8W27A, 5600 Fishers Lane, Rockville, 
Maryland 20857 or email at [email protected]. Requests should contain 
the name, address, telephone number, email address, and any business or 
professional affiliation of the person desiring to make an oral 
presentation. Groups having similar interests are requested to combine 
their comments and present them through a single representative.
    The allocation of time may be adjusted to accommodate the level of 
expressed interest. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may request at the 
time of the public comment period. Public participation and ability to 
comment will be limited to time as it permits.

FOR FURTHER INFORMATION CONTACT: Patricia Stroup, MBA, MPA, Executive 
Secretary, Healthcare Systems Bureau, Health Resources and Services 
Administration, 5600 Fishers Lane, Room 11C-06Q, Rockville, Maryland 
20857; telephone (301) 443-1127.

    Dated: May 7, 2014.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2014-10965 Filed 5-12-14; 8:45 am]
BILLING CODE 4165-15-P